Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Savvides · SciRah

Researcher profile · Semantic Scholar

P. Savvides

Share profile

P. Savvides — researcher profile on SciRah

h-index: 10
Works: 28
Citations: 570

Most-cited papers

A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome
Colin J. Mooney, G. Nagaiah, P. Fu, J. Wasman +11 more
2009Thyroid178 citations Open access
Semantic Scholar
Canalith Repositioning for Benign Paroxysmal Positional Vertigo
Judith A. White, P. Savvides, Neil Cherian, J. Oas
2005Otology and Neurotology94 citations
Semantic Scholar
A Phase II Study of Bevacizumab in Combination with Docetaxel and Radiation in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
M. Yao, N. Galanopoulos, P. Lavertu, P. Fu +7 more
2014Head and Neck51 citations Open access
Semantic Scholar
TROPION-Lung02: Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) in advanced non-small cell lung cancer (aNSCLC).
Y. Goto, Wu-Chou Su, B. Levy, O. Rixe +16 more
2023Journal of Clinical Oncology46 citations
Semantic Scholar
Cancer in the elderly.
N. Berger, P. Savvides, S. Koroukian, Eva Kahana +4 more
2006Transactions of the American Clinical and Climatological Association43 citations
Semantic Scholar
A phase I/II trial of cetuximab in combination with interleukin-12 administered to patients with unresectable primary or recurrent head and neck squamous cell carcinoma
Elizabeth L. McMichael, B. Benner, Lakhvir S. Atwal, Nicholas B. Courtney +20 more
2019Clinical Cancer Research39 citations Open access
Semantic Scholar
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report.
A. Desai, S. Rakshit, R. Bansal, Y. Ashara +16 more
2023Cancer Treatment and Research Communications25 citations Open access
Semantic Scholar
Development and validation of a patient-specific predictive instrument for the need for dose reduction in chemotherapy for breast cancer: a potential decision aid for the use of myeloid growth factors
P. Savvides, N. Terrin, J. Erban, H. Selker
2003Supportive Care in Cancer21 citations
Semantic Scholar
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer.
Aakash Desai, Caleb J. Smith, Y. Ashara, J. J. Orme +15 more
2023Clinical Lung Cancer20 citations Open access
Semantic Scholar
PHASE I CLINICAL TRIAL OF TEMOZOLOMIDE AND METHOXYAMINE (TRC-102), AN INHIBITOR OF BASE EXCISION REPAIR, IN PATIENTS WITH ADVANCED SOLID TUMORS
J. Eads, S. Krishnamurthi, J. Saltzman, J. Bokar +13 more
2020Investigational new drugs12 citations Open access
Semantic Scholar
Clinical outcomes and prognostic factors in cisplatin versus cetuximab chemoradiation for locally advanced p16 positive oropharyngeal carcinoma.
C. Barney, S. Walston, P. Zamora, E. Healy +17 more
2018Oral Oncology9 citations
Semantic Scholar
Final results from a phase I study of oral TRC102 (methoxyamine HCl), an inhibitor of base-excision repair, to potentiate the activity of pemetrexed in patients with refractory cancer.
G. Weiss, M. Gordon, L. Rosen, P. Savvides +6 more
20107 citations
Semantic Scholar
Phase 1 first-in-human study of PF-07257876, a novel CD47/PD-L1 bispecific checkpoint inhibitor, in patients with PD-1/PD-L1-refractory and -naïve advanced solid tumors.
B. Carneiro, H. Safran, J. Beck, O. Hamid +15 more
2023Journal of Clinical Oncology6 citations
Semantic Scholar
OC-0331: Cetuximab versus Platinum-based Chemoradiation in Locally Advanced p16 Positive Oropharyngeal Cancer
C. Barney, S. Walston, P. Zamora, N. Nolan +7 more
20174 citations Open access
Semantic Scholar
Abstract 753: Pharmacokinetic profile of the base-excision repair inhibitor methoxyamine-HCl (TRC102; MX) given as an one-hour intravenous infusion with temozolomide (TMZ) in the first in human phase 1 clinical trial
P. Savvides, Yan Xu, Li-Li Liu, L. Rogers +3 more
20123 citations
Semantic Scholar
Abstract 1743: Phase 1 clinical trial of the base-excision repair inhibitor Methoxyamine-HCl (TRC102; MX) in combination with Temozolomide (TMZ) in patients with solid tumors
P. Savvides, Yan Xu, Li-Li Liu, L. Rogers +4 more
20123 citations
Semantic Scholar
Osteotomy of the femoral neck for severe slipped capital femoral epiphysis
C. Coapes, I. Alcelik, P. Savvides, A. Adedapo +1 more
20073 citations Open access
Semantic Scholar
A phase II study of pemetrexed and pembrolizumab in patients (pts) with recurrent and/or metastatic (R/M) salivary gland cancer (SGC): Results from non-adenoid cystic cohort.
K. Price, N. Foster, E. Asmus, H. F. Fuentes Bayne +9 more
2025Journal of Clinical Oncology1 citations
Semantic Scholar
Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).
A. Mansfield, A. Goodrich, N. Foster, P. Savvides +13 more
2023Journal of Clinical Oncology1 citations
Semantic Scholar
Chemoimmunotherapy for the treatment of extensive-stage small cell lung cancer (ES-SCLC) in patients with an Eastern Cooperative Group (ECOG) performance status (PS) of two or greater.
D. Almquist, B. Langlais, Nathan Y. Yu, T. T. Sio +5 more
20211 citations
Semantic Scholar
Acute Skin Toxicity in Patients Treated with SBRT
N. Thawani, S. Srivastava, S. Jani, S. Mutyala +6 more
2019International Journal of Radiation Oncology, Biology, Physics1 citations
Semantic Scholar
Carboplatin-Based Chemoradiation Improves Outcomes Compared to Cetuximab Bioradiation in Cisplatin Ineligible Locally Advanced p16 Negative Head and Neck cancer
C. Barney, A. Branstetter, A. Yaney, E. Healy +10 more
20181 citations Open access
Semantic Scholar
Carboplatin Versus Cetuximab Chemoradiation in Cisplatin Ineligible Patients with Locally Advanced p16 Negative Head and Neck Squamous Cell Carcinoma
C. Barney, E. Healy, P. Zamora, J. Aljabban +10 more
20171 citations Open access
Semantic Scholar
A Phase II Study of Definitive Radiation Therapy With Concurrent Erlotinib and Docetaxel in Locally-Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)
C. Woods, M. Yao, R. Rezaee, C. Zender +6 more
20121 citations Open access
Semantic Scholar
Phase II Study of Concurrent Chemoradiation with Bevacizumab and Docetaxel for Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
N. Galanopoulos, M. Yao, P. Lavertu, A. Argiris +6 more
20111 citations
Semantic Scholar
Toxicity and outcomes of ipilimumab plus nivolumab in patients 80 years and older.
Haley M. Meyer, C. Dodoo, D. Walden, T. Ho +9 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract CT143: A phase I/II trial of cetuximab in combination with interleukin-12 administered to patients with unresectable primary or recurrent squamous cell carcinoma of the head and neck
Elizabeth L. McMichael, Amanda R. Campbell, M. Duggan, Tiffany Noel +13 more
20160 citations
Semantic Scholar
Development of a Cox proportional hazards (Cox-PH) model of time to first dose reduction in women undergoing breast cancer chemotherapy
P. Savvides, N. Terrin, J. Erban, H. Selker
20010 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Fu×5
Invite
P. Fu — researcher profile on SciRah
J. Wasman×4
Invite
J. Wasman — researcher profile on SciRah
A. Dowlati×4
Invite
A. Dowlati — researcher profile on SciRah
P. Lavertu×4
Invite
P. Lavertu — researcher profile on SciRah

×4

Invite

Y. Lou — researcher profile on SciRah

K. Leventakos×4

Invite

K. Leventakos — researcher profile on SciRah

Invite

V. Ernani — researcher profile on SciRah

A. Mansfield×4

Invite

A. Mansfield — researcher profile on SciRah

Invite

Yan Xu — researcher profile on SciRah

Invite

S. Gerson — researcher profile on SciRah

Invite

C. Barney — researcher profile on SciRah

Invite

S. Walston — researcher profile on SciRah